Levocetirizine: An Update

Author(s): Garry M. Walsh.

Journal Name: Current Medicinal Chemistry

Volume 13 , Issue 22 , 2006

Become EABM
Become Reviewer

Abstract:

Histamine plays a prominent and diverse role in the pathophysiology of allergic disease and therapeutic intervention is therefore typically focused on blocking the effects of this biogenic amine. A new antihistamine, levocetirizine, is the R-enantiomer of cetirizine dihydrochloride and like its parent compound undergoes minimal hepatic metabolism. Levocetirizine has pharmacodynamically and pharmacokinetically favourable characteristics, including high bioavailability, rapid onset of action, limited distribution and a low degree of metabolism. Clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic urticaria with a minimal number of untoward effects. Furthermore, several recent studies have demonstrated that, in addition to its being a potent antihistamine, levocetirizine has several anti-inflammatory effects that are observed at clinically relevant concentrations that may enhance its therapeutic benefit.

Keywords: Levocetirizine, antihistamine, allergy, anti-inflammatory

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 22
Year: 2006
Page: [2711 - 2715]
Pages: 5
DOI: 10.2174/092986706778201594
Price: $58

Article Metrics

PDF: 5